Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Friday, April 3, 2026.

Coherus Oncology, Inc. (NASDAQ:CHRS)

Bull Market Weakness (+75) - CHRS is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on CHRS as it may be in the beginning stages of a reversal.

Is it time to buy, sell, or avoid CHRS?

MarketClub looks at technical strength and momentum to determine if the timing is right for CHRS.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_CHRS
Open High Low CHRS Price Change
1.7000 1.7550 1.6847 1.7250 -0.0150
Entry Signal

MarketClub’s Trade Triangles for CHRS

long term up The long-term trend has been UP since Aug 22nd, 2025 at 1.15

intermediate term down The intermediate-term trend has been DOWN since Mar 19th, 2026 at 1.57

short term up The short-term trend has been UP since Apr 1st, 2026 at 1.73

Smart Scan Analysis for CHRS

Based on our trend formula, CHRS is rated as a +75 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

+75
Smart Scan Analysis for CHRS
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
1.7000 1.7550 1.6847 1.7250 -0.0150
Prev. Close Volume Bid Ask Time
1.7300 485326 2026-04-02 15:59:51
Year High20.662Year High Date2018-08-28
Year Low8.55Year Low Date2018-03-08
52wk High2.615852wk High Date2026-01-27
52wk Low0.7152wk Low Date2025-06-23
Average Volume1,474,541Shares Outstanding149,890
Assets258,343,000MLiabilities197,329,000M
P/E Ratio1.2168Volatility89.13
Get a free daily analysis and signals for Coherus Oncology, Inc. (CHRS) - Request Your Free Report.